You are viewing the site in preview mode

Skip to main content

Advertisement

Table 5 Newborn characteristics

From: Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women

  Korean subgroup (mean ± SD) Non-Korean subgroup (mean ± SD)
FCM (N = 45) FS (N = 44) FCM (N = 78) FS (N = 80)
Birthweight, kg 3.2 ± 0.4 3.2 ± 0.4 3.5 ± 0.5 3.5 ± 0.5
Birth length, cm 49.6 ± 2.4 49.4 ± 2.5 51.6 ± 2.5 51.5 ± 2.9
Cord hemoglobin, g/dL 14.9 ± 1.2 15.0 ± 1.3 14.7 ± 2.8 14.0 ± 2.0
Cord hematocrit, ratio 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
Cord serum ferritin, μg/L 269 ± 139 227 ± 117 242 ± 225 248 ± 155
1-min Apgar 9.5 ± 0.8 9.0 ± 1.4 8.2 ± 0.7 8.1 ± 1.3
5-min Apgar 9.4 ± 0.6 9.1 ± 0.8 9.0 ± 0.6 8.9 ± 0.8
  1. Values with no asterisk have no statistically significant difference when compared with other three values in the same row using Student’s t-test
  2. FCM ferric carboxymaltose, FS ferrous sulfate